This volume describes selected examples of both diagnostic and therapeutic progress in areas of Hematological malignancies and common human solid tumors, with emphasis in research that has immediate or very short-term clinical application. The expanded understanding of the processes of malignant transformation, invasion and metastasis has contributed to exciting developments in the area of targeted interventions, both in diagnostic and therapeutic areas. The past two decades have also witnessed substantial advances in biomedical technology, advances that have contributed substantially to accelerating the pace of discovery.
New Drug Combinations in NSCLC: progress in anti cancer therapy; Protecting human subjects from risk in the perfomance of clinical research and the informed consent process; Screening for prostate cancer: the good, the bad and the ugly; Update in testicular cancer; Clinical applications of angiogenesis inhibitors; Progress and perspectives in the chemotherapy of epithelial solid tumors; Current management and new leads in small cell lung cancer; Epstein-Barr virus and malignant diseases; Helicobacter Pylori and malignant diseases; Hereditary breast cancer: an overview; The development of cancer vaccines for the treatment of metastatic melanoma; Progress in lung cancer surgery; High risk soft tissue sarcoma: an overview; Advances in the management of pancreatic cancer; The role of interferon in the adjuvant treatment of cutaneous melanoma.
Series: Progress in Anti-Cancer Chemotherapy
Number Of Pages: 307
Publisher: SPRINGER VERLAG GMBH
Country of Publication: FR
Dimensions (cm): 23.39 x 15.6
Weight (kg): 0.45